Treating scabies: Results from an updated Cochrane review

Archives of Dermatology

Volumn 144, Issue 12, 2008, Pages 1638-1640

  Hu, Stephanie ^a   Bigby, Michael ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Department of Dermatology ^*  (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL BENZOATE; CROTAMITON; DELTAMETHRIN; HERBACEOUS AGENT; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN; PLACEBO; PYRETHRIN; SULFUR;

CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE RESISTANCE; DRUG DOSE COMPARISON; DRUG EFFICACY; HUMAN; META ANALYSIS; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCABIES; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

EID: 58049208121     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.513     Document Type: Note

References (4)

1. Hengge UR, Currie BJ, Jager G, Lupi O, Schwartz RA. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6(12):769-779.
2. Center for Evidence-Based Medicine. Systematic review critical appraisal sheet. http://www.cebm.net/index.aspx?o=1157. Accessed March 20, 2008.
3. Bigby M, Williams HC. Appraising systematic reviews and meta-analyses. In: Williams HC, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B, eds. Evidence-Based Dermatology. 2nd ed. London, England: BMJ Books; 2003.
4. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet. 1997;349(9059):1144-1145.